ertapenem has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbey, A; Farrar, H; Nair, R; Patel, V | 1 |
| Ayaz, T; Kara, E; Sahin, OZ; Sahutoglu, T; Tufekci, A; Yildirim, S | 1 |
2 other study(ies) available for ertapenem and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Osteomyelitis, discitis, epidural and psoas abscess secondary to Salmonella enterica in a man with diabetes mellitus and newly diagnosed α-thalassaemia trait.
Topics: Aged; alpha-Thalassemia; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Discitis; Ertapenem; Humans; Laminectomy; Male; Meropenem; Osteomyelitis; Psoas Abscess; Salmonella enterica; Thienamycins; Treatment Outcome | 2015 |
Ertapenem-induced acute reversible peripheral neuropathy in chronic kidney disease: 3 case reports.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Diabetes Mellitus, Type 2; Electroencephalography; Electromyography; Enterococcus faecalis; Ertapenem; Escherichia coli Infections; Gram-Positive Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Renal Insufficiency, Chronic; Risk Factors; Urinary Tract Infections | 2015 |